Stocks & Investing
Tue, February 21, 2023
[ Tue, Feb 21st 2023
] - WOPRAI
Wed, February 8, 2023
[ Wed, Feb 08th 2023
] - WOPRAI
Thu, January 19, 2023
[ Thu, Jan 19th 2023
] - WOPRAI
[ Thu, Jan 19th 2023
] - WOPRAI
Wed, January 11, 2023
[ Wed, Jan 11th 2023
] - WOPRAI
Mon, December 12, 2022
[ Mon, Dec 12th 2022
] - WOPRAI
Fri, October 14, 2022
[ Fri, Oct 14th 2022
] - WOPRAI
Wed, August 17, 2022
[ Wed, Aug 17th 2022
] - WOPRAI
Tue, July 26, 2022
[ Tue, Jul 26th 2022
] - WOPRAI
[ Tue, Jul 26th 2022
] - WOPRAI
[ Tue, Jul 26th 2022
] - WOPRAI
Fri, July 15, 2022
[ Fri, Jul 15th 2022
] - WOPRAI
Thu, June 23, 2022
[ Thu, Jun 23rd 2022
] - WOPRAI
Tue, May 17, 2022
[ Tue, May 17th 2022
] - WOPRAI
Wed, May 11, 2022
[ Wed, May 11th 2022
] - WOPRAI
Fri, May 6, 2022
[ Fri, May 06th 2022
] - WOPRAI
[ Fri, May 06th 2022
] - WOPRAI
Fri, April 22, 2022
[ Fri, Apr 22nd 2022
] - WOPRAI
Thu, March 31, 2022
[ Thu, Mar 31st 2022
] - WOPRAI
[ Thu, Mar 31st 2022
] - WOPRAI
Fri, November 19, 2021
[ Fri, Nov 19th 2021
] - WOPRAI
[ Fri, Nov 19th 2021
] - WOPRAI
[ Fri, Nov 19th 2021
] - WOPRAI
Tue, February 2, 2021
[ Tue, Feb 02nd 2021
] - WOPRAI
Mon, January 25, 2021
[ Mon, Jan 25th 2021
] - WOPRAI
Tue, January 5, 2021
[ Tue, Jan 05th 2021
] - WOPRAI
Fri, December 18, 2020
[ Fri, Dec 18th 2020
] - WOPRAI
Thu, May 7, 2020
[ Thu, May 07th 2020
] - WOPRAI
Thu, April 30, 2020
[ Thu, Apr 30th 2020
] - WOPRAI
Mon, November 25, 2019
[ Mon, Nov 25th 2019
] - WOPRAI
Do Kim Maintained (TVTX) at Buy with Increased Target to $46 on, Feb 21st, 2023
Do Kim of Piper Sandler, Maintained "Travere Therapeutics, Inc." (TVTX) at Buy with Increased Target from $42 to $46 on, Feb 21st, 2023.
Do has made no other calls on TVTX in the last 4 months.
There are 2 other peers that have a rating on TVTX. Out of the 2 peers that are also analyzing TVTX, 1 agrees with Do's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Alex Thompson of "Stifel" Initiated at Hold and Held Target at $22 on, Wednesday, December 14th, 2022
This is the rating of the analyst that currently disagrees with Do
- Edward Nash of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $40 on, Monday, January 30th, 2023
